EUVIMEDEUVIMED entdecken
Open Access

Integrase strand transfer inhibitors resistance-associated mutations in HIV-infected pregnant women

D Cecchini, J Sfalcin, I Zapiola, A Gomez, S Fernandez-Giuliano, C Rodriguez, L Mammana, A Seravalle, F Fay, M C Torroija, G Bugarín, M B Bouzas

Revista Española de Quimioterapia · 2024

DOI: 10.37201/req/074.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Española de Quimioterapia, 2024. Verfasst von D Cecchini und 11 weiteren Autor:innen. Beteiligte Einrichtung: Diego Cecchini, Infectious Diseases Unit, Hospital Cosme Argerich, Almirante Brown 240, Buenos Aires 1155AHD, Argentina. diegocec@gmail.com. Hauptthemen laut MEDLINE: HIV Infections, Drug Resistance, Viral, HIV Integrase Inhibitors, Mutation. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To date, no data exist regarding the prevalence of integrase inhibitor (INSTI) resistance-associated mutations (HIVDRM) in HIV-infected pregnant women (HPW) in Latin America. We describe the prevalence and transmissibility of integrase HIVDRM in a historical cohort of INSTI-naïve HPW from Argentina (n=56) with Next Generation Sequencing (NGS). Material and methods. Bioinformatics analysis was performed by HyDRA software for 20%, 10%, 5%, 2%, and 1% sensitivity thresholds. We calculated the mutational viral load for each INSTI-HIVDRM, considering those with >1000 c/mL as of high risk of transmissibility.

Results

The predominant HIV subtype was BF (78.5%). Major HIVDRM were not detected with the population sequencing 20% filter. With a 1% threshold, the prevalence increased to 8.9%; Y143C/S, E92G, E138K, and T66I mutations were found. The median (range) mutational load (expressed in c/mL) was: 355 (50.2-11705); with only 1 case >1000 c/mL Accessory mutations (G163R/K, T97A) were detected mostly with a 20% sensitivity threshold with an overall prevalence of 23.2%; the median (IQR) mutational load was: 23929 (4009-63158) c/mL; all of them above 1000 c/mL.

Conclusion

Our results show evidence of the presence of major INSTI-HIVDRM as aleatory mutations and a high frequency of accessory mutations with potential transmissibility in HPW.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsDrug Resistance, ViralHIV Integrase InhibitorsMutationPregnancy Complications, InfectiousViral LoadHumansFemalePregnancyAdultArgentinaHigh-Throughput Nucleotide SequencingHIV-1HIV IntegraseCohort StudiesYoung AdultPrevalence

Stichwörter der Autor:innen

HIVintegrase inhibitorsmutationspregnant womenprevalence

Substanzen

HIV Integrase InhibitorsHIV Integrase

Autor:innen und Institutionen

  • Diego Cecchini, Infectious Diseases Unit, Hospital Cosme Argerich, Almirante Brown 240, Buenos Aires 1155AHD, Argentina. diegocec@gmail.com.

Zitieren

APA

Cecchini, D., Sfalcin, J., Zapiola, I., Gomez, A., Fernandez-Giuliano, S., Rodriguez, C., Mammana, L., Seravalle, A., Fay, F., Torroija, M. C., Bugarín, G., & Bouzas, M. B. (2024). Integrase strand transfer inhibitors resistance-associated mutations in HIV-infected pregnant women. Revista Española de Quimioterapia. https://doi.org/10.37201/req/074.2024

Vancouver

Cecchini D, Sfalcin J, Zapiola I, Gomez A, Fernandez-Giuliano S, Rodriguez C, et al. Integrase strand transfer inhibitors resistance-associated mutations in HIV-infected pregnant women. Revista Española de Quimioterapia. 2024. doi:10.37201/req/074.2024

BibTeX
@article{Cecchini2024,
  author = {Cecchini, D and Sfalcin, J and Zapiola, I and Gomez, A and Fernandez-Giuliano, S and Rodriguez, C and Mammana, L and Seravalle, A and Fay, F and Torroija, M C and Bugarín, G and Bouzas, M B},
  title = {Integrase strand transfer inhibitors resistance-associated mutations in HIV-infected pregnant women},
  journal = {Revista Española de Quimioterapia},
  year = {2024},
  doi = {10.37201/req/074.2024}
}
Kostenlos starten →